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Abstract
Background: The prescribing rates of psychotropic medication for foster children far exceed the
prescribing rates of psychotropic medications for other children, ages 0-18. Many psychotropic
medications have not been researched for children and have not been proven safe or effective for
this age group, and do not adhere to AACAP safety guidelines.
Objectives: The purpose of this integrative literature review is to identify the factors that
contribute to the high prescribing rates of psychotropic medication among foster children, as well
as identifying the risks associated with prescribing habits that do not follow AACAP guidelines.
Additionally, safer alternatives to psychotropic medications will be assessed.
Methods: An integrative literature review was conducted following the Whittemore & Knafl
guideline. Databases searched included: CINAHL, ProQuest Nursing, PubMed, ProQuest
Sociology, and PsycINFO. Included articles were related to foster children, ages 0-18, and were
published between 2008-2018. Eighteen articles were selected for review.
Results: Trends that are correlated with high prescribing rates were based on demographics,
diagnosis, prescriber and medication type, and fragmented care. Additionally, the risks
associated with prescribing habits that do not follow AACAP guidelines were: polypharmacy,
exorbitant and off label antipsychotic use, receiving a treatment plan that does not follow
evidence-based practice, and receiving medication before proper mental health screenings were
completed. Furthermore, alternative options that can limit the amount of psychotropic
medications prescribed and better ensure medication safety are: psychosocial treatment,
treatment foster care, and the “Fostering Healthy Futures” program.
Conclusion: Psychotropic medications are being prescribed without utilizing the AACAP
protocols effectively. Additionally, safer first line treatments, such as psychological therapy,
could be used in place of medications to increase safety and decrease negative long-term effects
for foster children who are prescribed psychotropic medication.
Key Words: foster children, overmedication, polypharmacy, psychotropic
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Introduction
Background and Significance
Foster care is a growing phenomenon in the United States. According to the Adoption
and Foster Care Analysis and Reporting System (2014), in the year 2014, an estimated 415,129
children in the U.S., ages 0-18, were part of the foster care system. The American Academy of
Child and Adolescent Psychiatry (AACAP) lists several reasons why a child would be placed in
foster care, such as a child being abused, neglected, or abandoned by his parents (AACAP,
2015). Trends have shown increasing numbers of children in the foster system over the last three
years and fewer adoptions (Davenport, 2015). Transferring a child into foster care puts the child
under tremendous stress and this stress is compounded by the trauma endured from possible
abuse in the child’s previous home (AACAP, 2015).
Psychotropic medications, also known as psychoactive medications, are drugs that affect
a person’s emotions, thoughts, and behaviors (Scott, 2009). The word psychotropic comes from
the Greek words “psycho” and “trop”, which literally translate to turning the mind, because that
is what these medications are intended to do (Online Etymology Dictionary, 2017). Psychiatric
disorders cause there to be too much or too little transmission of a specific neurotransmitter in
the brain. Psychotropic drugs operate by activating a neurotransmitter that will either inhibit or
potentiate an electrical impulse to correct the existing imbalance. The main categories of
psychoactive medications are antidepressants, mood stabilizers, psychostimulants, antianxiety
drugs, and antipsychotic drugs (Scott, 2009).
The U.S. Government Accountability Office (GAO) released a report in 2011 after
auditing the trends of prescribing psychoactive drugs to foster children, ages 0-18, in five states
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(Lord, 2014). The audit uncovered that foster children were being prescribed psychotropic
medications at an average rate that was 4.5 times higher than their peers. The report also found
that thousands of foster children across the U.S. were prescribed more than five psychotropic
medications concurrently, with no evidence supporting this method of treatment. In fact,
polypharmacy increases both adverse and long-term effects of treatment, as well as making it
difficult to discern which medication is responsible for positive outcomes. Additionally, the
report uncovered that thousands of foster children were prescribed psychotropic medications at
amounts that surpassed the FDA approved doses. Furthermore, the report indicated that 6.5% of
foster children were prescribed antipsychotic medication, which is an extremely potent group of
medications with severe side effects. The average age of the children taking antipsychotics was
between 6-11 years old, and many antipsychotics have not been proven safe or effective for
children. (Lord, 2014).
In the last 20 years, foster care has grown 65% (Steele & Buchi, 2008). One study found
that 71% of foster children were given psychotropic medication compared to 3.9% of youth in
the general population (Warner, Song, & Pottick, 2014). Zito et al. (2008) found 72.5% of foster
youth were taking psychotropic medications, while dosReis et al. (2011) found the prevalence of
psychotropic medication use can be as high as 77% among foster youth. These rates highlight a
steadily increasing trend in prescribing psychotropic medication to the foster population, yet
studies lack evidence of the effectiveness of the treatment regimens and disregarded safety
concerns, especially in an adolescent population (Steele & Buchi, 2008).
The AACAP created protocols to ensure the proper prescribing of psychotropic drugs for
foster children (Lee, Foras, & Brown, 2015). The first requirement outlined is that after a child is
removed from his home, he is required to receive a mental health screening and assessment to
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determine if any trauma treatment is necessary. If psychotropic drugs are utilized for treatment, a
psychiatric evaluation must be done. Additionally, all stakeholders must be informed about the
medication plan, be part of the decision-making process, and the responsible stakeholder must
consent to the medication and the minor must assent to it. The prescribing physician must then
establish guidelines for the medication use and monitor the medications effect over time. While
it is the intention of many physicians and caseworkers to be constantly active in the medicating
process, heavy caseloads and time limits often prevent adequate monitoring and joint planning.
Additionally, there are currently no requirements for medication training in a regular foster care
home, and the physician has no obligation to provide further resources for foster parents to
understand medication regimens (Lee, Foras, & Brown, 2015).
Despite the AACAP guidelines, higher rates of mental disorders and prescribing of
psychotropic medication creates a major risk for the foster population (Lord, 2014). While all
medications have side effects, the risks and potential adverse effects of psychotropic medication
in the adolescent population is not well understood. It is evident that foster children are
prescribed medications much more than the general population. It is unclear if there is proper
understanding and adherence to the medication regimen or if the types, dosages, number of
concurrent medications, and ages at which foster children begin taking psychotropic medications
are safe or the best course of treatment (Lord, 2014).
Purpose Statement
The purpose of this integrative literature review is to better understand the factors
associated with over-prescription of psychotropic medications to foster children as defined by the
AACAP guidelines and to ascertain what risks are associated with high prescribing rates.
Additionally, this review will determine alternative treatments to remedy this growing problem.

INAPPROPRIATELY MEDICATING FOSTER CHILDREN

6

Research Questions
The following research questions will guide this study:
1. What factors contribute to high prescribing rates of psychotropic medications among
foster children?
2. What risks are associated with prescribing psychotropic medication to foster children that
do not follow AACAP guidelines?
3. What alternatives to psychotropic medications can effectively manage mental illness in
foster children?
Conceptual Framework
The conceptual framework for this paper is Neuman’s system model. This model focuses
on how a person responds to stressors in his or her environment, which is referred to as an open
system. Biological, mental, environmental, sociocultural, developmental, and spiritual factors are
all interrelated pieces that compose the system. A healthy individual can adapt to stressors in any
of these capacities. The system model is therefore considered a holistic model of care (Neuman,
& Fawcett, 2011).
In Neuman’s model, the basic functions of life, such as genetic structure and baseline
physiology, are at the center of the circle. Concentric circles around the core called lines of
resistance (LOR) are factors that protect a person against stress. The outermost circle is called
the flexible line of defense (FLD) and just within that circle is the normal line of defense (NLD).
The FLD acts as a first line barrier against the stressors and the more flexibility that the line has,
the less the stress will affect a person. The NLD represents a person’s normal healthy state, and it
is not good at shielding against stress. The NLD indicates the stability of the system. When both
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lines of defense are broken, the lines of resistance are relied upon to protect an individual from
harm. The LOR utilizes a variety of internal and external factors to support the NLD and return
the individual to a healthy state. Neuman’s system model is guided by prevention, and nurses can
use primary, secondary, and tertiary prevention to help patients adapt to stress. Primary
prevention creates a more flexible FLD by reducing stress risk factors. Secondary prevention is
used when the NLD is breached by stress and the tension must be diagnosed and treated. Lastly,
tertiary prevention focuses on adapting and finding stability after a stressful period. The system
model is depicted in Figure 1 (Neuman, & Fawcett, 2011).
Foster children are in a very high stress system. Each stressor the children encounter
weakens their lines of defense and leaves them vulnerable. A break in the system from
environmental stressors seems to affect the psychological variable most often in foster children.
Interventions such as therapy could act as a primary prevention strategy by educating foster
children about healthy coping mechanisms and managing stressors to strengthen weakened lines
of defense. With secondary prevention, damage has already been done to the system and the
focus is on ensuring that the damage to the system does not reach the core. At this point,
medication may be necessary. It is possible that utilizing more primary prevention for children in
foster care could limit the need for medication, as well as limiting the severity of damage to
child’s system from stress.
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Figure 1. The Neuman system model (Neuman, 2011).
Methods
Research Design
An integrative literature review was conducted to address the research questions
proposed in this study. The review analyzes and comprehensively summarizes the selected
sample of studies to create a picture of the overuse of psychotropic medication for the foster
youth population. Both quantitative and qualitative studies are included in the review. This
literature review will help nurses gain a better understanding of the issue at hand and advocate
for the best interest of their patients who meet these criteria.
Literature Search Strategies
A computerized search was completed utilizing several databases, including the
Cumulative Index to Nursing and Health Literature (CINAHL), PsycInfo, ProQuest Nursing and
Allied Health Source, ProQuest Sociology Collection, and PubMed. Searches were done on these
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databases with a variety of combinations of key words which included foster children, foster
system, foster care, foster parents, foster home care, psychotropic drugs, psychotropic
medications, hypnotics, antianxiety agents, tranquilizing agents, antipsychotics, and
antidepressive agents. The word foster was searched with the limiter of subject heading to ensure
that the subjects in the selected articles are part of the foster system.
Literature Search Limitations and Inclusion/ Exclusion Criteria
Articles used in this literature review include those relating to children in the foster care
system, ages 0-18. Furthermore, articles are connected to the keywords used in the database
search; however, to ensure the database search isolates the most relevant results, the word foster
will be required to be a major subject heading for the search criteria. Additional inclusion criteria
are that the article is peer reviewed, written in English, identified as a research or journal article,
is a primary source, is published after the year 2008, is a quantitative or qualitative study, and
that the study is done in the U.S. The articles that met these criteria were read and evaluated for
use on an individual basis. Articles were excluded if the research participants were not specified
as foster children, if the study was done in a language other than English, if the article was a
literature review or case study, if the article was written before 2008, if participants were
primarily over 18 years old, or if the study was pertaining to foster care outside of the U.S. Of
the 6,402 articles identifies in the databases using key word searches, eighteen articles were
selected after determining that all inclusion and exclusion criteria were met. Table 1 depicts the
way the articles were selected based on the inclusion and exclusion criteria listed above.
Data Synthesis and Analysis
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Eighteen articles were included in the literature review. All articles included outcomes of
foster children who were prescribed psychotropic medication. Data synthesis and analysis was
done with the framework of Whittemore and Knafl (2005). Each article was individually
reviewed for related content and divided into subgroups to further facilitate the analysis for data
reduction. Data was congregated and exhibited based on variables, such as the author, year
written, sample, alternative treatments, and results. Data is displayed in a matrix for clear
comparison of all variables. Data comparison was done to find themes and answer the proposed
research questions. Table 2 lists selected articles in a clear way for data analysis.
Results
The results are categorized based on the proposed research questions. The first section
will highlight trends that are correlated with high prescribing rates, such as demographics,
diagnosis, prescriber and medication type, and fragmented care. The second section will analyze
the risks associated with prescribing habits that do not follow AACAP guidelines, such as
polypharmacy, exorbitant and off label antipsychotic use, receiving a treatment plan that does
not follow evidence-based practice, and receiving medication before proper mental health
screenings and diagnosis are completed. The final section will consider alternative options that
can be utilized to limit the amount of psychotropic medication prescribed and can better ensure
medication safety, such as psychosocial treatment, treatment foster care, and the “fostering
healthy futures” program.
Factors Associated with Prescribing Trends
Demographics. White, male children, on the older end of the spectrum were found to be
the most likely to be prescribed a psychoactive medication and were most likely to struggle
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behaviorally (Raghavan, Lama, Kohl & Hamilton, 2010; Steele & Buchi, 2008; Warner, Song, &
Pottick, 2014). Moreover, Zito et al. (2008) found that white males between the ages 10-14 were
most likely to be prescribed psychotropic medication and Brenner et al. (2014) found that 6-12year olds had highest medication use. Medication rates were found to be higher among Medicaid
insured foster children and varied depending on demographic location, drastically differing from
state to state (Warner, Song, & Pottick, 2014). One study found that predictors were more
location based then individual or diagnosis based (Raghavan, Lama, Kohl & Hamilton, 2010),
Urban areas have a higher incidence of psychotropic medication oversight (Mackie et al., 2011)
and the southwest states have highest prevalence of prescribing psychotropic medication (Zito et
al., 2008). Other studies found that symptoms were the greatest predictor of prescribing rates
(Brenner et al., 2014).
Diagnosis. While the high prescribing rates of psychotropic medications may be part of a
growing trend of physicians prescribing more over the past 10 years, the high rates of
psychotropic use among the foster population is also due to the prevalence of behavioral and
emotional issues consistent in this population (Mackie et al., 2011). Zito et al. (2008) found that
of the children being treated with psychotropic medication, 39% of kids were being treated for
ADHD, 36% for depression, 34% for anxiety, and, 21% for conduct disorders, and 17% for
bipolar disorder. Raghavan & McMillen (2008) found that 45% of foster children were
diagnosed with at least one DSM IV diagnosis. The most common diagnoses among foster
children receiving psychotropic medication was ADHD (55%) followed by anxiety (52%)
(Linares, Martinez- Martin, & Castellanos, 2013).
Provider and Medication Type. Zito et al. (2008) found that in a general random
sample of children in foster care, psychiatrists prescribed 93% of psychotropic meds to foster
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children, as opposed to primary care providers (PCP). Zito et al. (2008) also found that
psychiatrists are more likely to prescribe antipsychotics and lithium then antidepressants and
anxiolytics like PCP’s. Alternatively, Brenner et al. (2014) found that foster children are more
often prescribed psychotropic medication from a non-psychiatrist. Brenner et al. (2014) and
Raghavan & McMillen (2008) found that antidepressants were the most common medication
prescribed, comprising 67% of the psychotropic medications, whereas Linares, Martinez- Martin,
& Castellanos (2013) found that the most common medication prescribed was stimulants (69%)
followed by atypical antipsychotics at (65%). The most common combination of medications
was antidepressants and antipsychotics (Raghavan & McMillen, 2008).
Fragmented Care. One cause of high prescribing rates of psychotropic medication for
children in foster care is discontinuity of care (Fontanella, Gupta, Hiance-Steelesmith, &
Valentine, 2015). Limited access to quality care, frequently changing guardianship, and
providers being unable to access medical charts were the primary barriers that led to fragmented
care in this population (Steele & Buchi, 2008). Having a constant source of care, having a
relationship with the same provider time after time, having an individualized plan of care, having
a reliable source to monitor treatment outcomes are all important factors in ensuring proper, safe
and effective treatment (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). Foster
children rarely have continuity of care, and frequent disruptions in care can risk adherence to
already complex medication routines, as well as monitoring for adverse reactions to medication
(Warner, Song, & Pottick, 2014). Because of a lack of continuous care, many foster children do
not get the required mental health screenings and do not have sufficient primary care, which is
the first barrier of defense when it comes to consistently monitoring treatment plans (Fontanella,
Gupta, Hiance-Steelesmith, & Valentine, 2015). Fragmented care also jeopardizes proper
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medication reconciliation which can lead to patients receiving multiple psychotropic medications
in the same class (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). Additionally,
some foster parents were told that their foster child had a mental health condition but were not
able to obtain resources or appointments for several months (Hayes, Geiger, & Lietz, 2015).
Fontanella, Gupta, Hiance-Steelesmith, & Valentine (2015) found that of 93.6% of foster
children who were diagnosed with bipolar disorder, only 46% had regular outpatient visits and
more than 31% of the sample had a gap in care of 60 days or more. Another sample showed that
more than half of foster children with severe emotional disorders taking psychotropic medication
did not receive monthly outpatient treatments, which is considered a minimal requirement of care
(Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). Moreover, continuity of care is
associated with positive effects such as improved health outcomes, increased medication
adherence, improved preventative care, decreased emergency and hospital visits and lower
expenditures (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015).
Risks Associated with Non-Protocol Prescribing
Polypharmacy. Psychotropic polypharmacy is described as taking three or more
psychotropic medications concurrently (Rubin et al., 2012). Polypharmacy is more prevalent
among foster youth then the general population (Warner, Song, & Pottick, 2014). In 2008,
Raghavan & McMillen found that the prevalence of polypharmacy was 10% among foster
children, while Brenner et al. (2014) found that the rate of polypharmacy was 25%, and Mackie
et al. (2011) found that 41.3% of foster youth exhibited polypharmacy. Rubin et al. (2012) found
that 20% of those who displayed polypharmacy were taking multiple medications in the same
drug class. For those receiving 5 or more psychotropic medications, antipsychotics were the most
common concomitantly prescribed drug (Zito et al., 2008).
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Antipsychotic Use. Rubin et al., (2012) found that 10% of foster children were taking
antipsychotics, while Zito et al., (2008) found that 22% were taking antipsychotics.
Antipsychotics are mainly used to treat schizophrenia, bipolar, and autism disorders, however
antipsychotics are prescribed most often to foster children for off label uses (Rubin et al., 2012).
dosReis et al., (2011) found that, 53% of foster children taking antipsychotic medications were
prescribed the medication as a treatment for ADHD and 34% for the treatment of depression,
which are off label uses. Also, psychotropic medications are being prescribed to foster children
at increasing rates to treat disruptive behaviors (Rubin et al., 2012). dosReis et al., (2011),
Raghavan & McMillen, (2008), and Rubin et al., (2012) found that nearly all the antipsychotics
prescribed were second generation antipsychotics, also known as atypical antipsychotics. Second
generation antipsychotics are strongly linked to adverse metabolic effects, such as the
development of type 2 diabetes, dyslipidemia, and weight gain (Cohen, Lacasse, Duan &
Sengelmann, 2013; dosReis et al., 2011; Rubin et al., 2012), as well as pathological cholesterol
changes, and negative effects in the cardiac and neurologic systems (Cohen, Lacasse, Duan &
Sengelmann, 2013). Children were discovered to develop these metabolic disorders in relation to
atypical antipsychotics 5.1 times more often than the adult population (dosReis et al., 2011).
Additionally, despite the lack of evidence to suggest the efficacy of polypharmacy or analyze the
risks that may come with it, more than 38% of foster children were concomitantly prescribed an
additional psychotropic medication together with their antipsychotic medication (dosReis et al.,
2011). Finally, over 20% of the children in foster care taking antipsychotics were prescribed
more than one antipsychotic medication concurrently (Rubin et al., 2012).
Lack of Evidence Based Practice. Even though many foster children have mental health
needs, very few receive treatment formulated with evidence-based practice, which includes
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training children and parents to understand negative side effects of medication, proper
medication administration, and to ensuring that each child receives a full mental health
evaluation with an accurate diagnosis before prescribing medication (Scozzaro & Janikowski,
2015). There is limited evidence regarding the effectiveness of psychotropic medication among
foster children, with complete disregard for functional outcomes, potential for long term
durability, and the safety consequences of the treatment regimen for the children (Cohen,
Lacasse, Duan & Sengelmann, 2013). Zito et al. (2008) found that all the atypical antipsychotics
used by the children in the study were utilized for off label uses without approval from the FDA
for dosage and indication in this age group and that 74% of SSRI being prescribed were not
approved for adolescents and children. Linares, Martinez- Martin, & Castellanos (2013) found
that antipsychotic medications are often combined with stimulant medications to treat ADHD
and to treat aggressive behavior although it has not been approved for this population. Brenner et
al. (2014) found that 7% of children 0-5 in his study were receiving psychotropic medications,
despite regulations stating that children of this age group should not be prescribed any
psychotropic medication at all. Additionally, using more than two antipsychotic medications
concurrently is not an evidenced based practice and it increases the risk of adverse effects, yet
20% of people taking antipsychotics were taking more than one drug in the same class (Rubin et
al., 2012). Also, despite evidence-based practice suggesting monthly psychiatric visits while
taking psychotropic drugs, only 42% of adolescents stated that they had seen a psychiatrist in last
two months (Brenner et al., 2014). More than 50% of people taking a psychotropic medication
were not seeing a psychologist or receiving adjunct social service treatment, as evidence based
practice suggests (Brenner et al., 2014).
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Lack of Appropriate Screening. Children in foster care are more likely to have mental
health care needs which is why more emphasis needs to be placed on ensuring timely mental
health evaluations at the time children enter care, following the recommendation of the American
Academy of Pediatrics and the Child Welfare League of America (Steele & Buchi, 2008). It is
essential that all children get screened for mental illness because there is a proven correlation
between being part of a traumatic event, like abuse, and having traumatic symptoms that are
indicative of mental illness (Griffin et al., 2011). Almost 80% of foster children have significant
emotional and behavioral problems, as well as being eight times more likely than their peers to
be hospitalized for a psychiatric disorder (Williams & Sherr, 2009). Foster children were
reported to be diagnosed with mental health conditions ten times more than other children in the
Medicaid system, and receiving a proper mental health screening increased the likelihood of
proper medication and psychosocial treatment following evidenced based practice (Steele &
Buchi, 2008). Receiving medication oversight and extra services such as case management,
social services, school services, outpatient treatment, and psychiatric visits were highly
correlated with number of medications prescribed and increased with each additional medication
(Brenner et al, 2014). One study found that more than half of foster children that participated did
not receive a mental health evaluation (dosReis et al., 2011).
Alternative/Safer Treatment Options
Psychosocial Treatment. Children in foster care use mental health services at a rate 20
times that the general population (Linares, Martinez- Martin, & Castellanos, 2013). More than
50% of the children in foster care have some type of emotional or behavioral problem, but only
55% of those children receive mental health services and treatment that follow national standards
(dosReis et al., 2011; Scozzaro & Janikowski, 2015). Despite several organizations creating
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standards of care for medicating foster children, few state and county health administrators stated
that they knew that these standards existed (Warner, Song, & Pottick, 2014). According to the
standards of care psychotropic medication should not be provided before foster children begin
counseling and psychotherapy, and once the child begins therapy the therapy should continue
concurrently with the medication treatment (Scozzaro & Janikowski, 2015). For 50% of foster
care children, psychotropic medication was the sole treatment for their mental health issues,
lacking any adjunct psychosocial treatment (Warner, Song, & Pottick, 2014). A study found that
only 33% of the children who were given psychotropic medication received behavioral health
care along with it (Mackie et al., 2011; Scozzaro & Janikowski, 2015). Fontanella, Gupta,
Hiance-Steelesmith, & Valentine (2015) found that 30% of children who required mental health
services received none during a yearlong period. Taussig & Culhane (2010) found that within a
group of foster children, 42% met diagnostic criteria for a DSM diagnosis and 57% met criteria
for a mental health disorder, yet most of the children in the study did not receive any
psychosocial therapy (Hayes, Geiger, & Lietz, 2015). Warner, Song, & Pottick (2014) found that
only 10% of youth in foster care being treated with psychotropic medication received concurrent
individualized therapy and only 5% received behavioral therapy. Foster parents stated that they
were concerned when Medicaid would only approve 4-8 sessions for children to resolve serious
emotional and behavioral issues, and many were told that if they want any behavioral counseling
that they would likely have to pay out of pocket (Hayes, Geiger, & Lietz, 2015). One study
found that the only trauma related diagnosis in the DSM is PTSD, so children with lesser trauma
symptoms either get overtreated or not treated at all (Griffin et al., 2011). Better practice to treat
trauma symptoms would be to help the children develop more strengths and protective factors
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against trauma, to focus less on treatment with medications, and focus more on risk behaviors,
safety, and support (Griffin et al., 2011).
Psychosocial treatment may be effective as sole first line treatment for moderate mental
health issues. Williams & Sherr (2009) found that psychosocial treatment was equally as
effective for treating foster children with severe emotional and behavioral issues as it is in
treating the general population despite its limited use, and that therapy was more effective when
focusing on the child’s strength (Williams & Sherr, 2009).
Treatment Foster Care. Treatment foster care (TFC) is a community based intensive
treatment intervention for foster children with emotional, behavior, and mental health problems
(Brenner et al., 2014). In TFC, “treatment foster parents” work as primary caregivers who obtain
more training and ensure more supervision of treatments then regular foster parents (Brenner et
al., 2014). Brenner et al. (2014) conducted a study and found that 59% of children in TFC take
psychotropic medication. For foster children with severe behavioral issues, treatment foster care
was found to be more effective at treatment, reducing criminal actions, and ensuring adjunct
treatment and services (Robst, Armstrong, & Dollard, 2011).
Fostering Healthy Futures. Fostering Healthy Futures (FHF) is a program that
combines skills group and mentoring to achieve better self-esteem, social support, social
acceptance, and coping skills for foster children that were abused. In a randomized controlled
trial, it was concluded that 9 months of treatment at FHF significantly reduced mental health
symptoms in the children that participated. There was a decrease in symptoms of anxiety,
depression, suicidality, and trauma, and the children had improved quality of life. After the
program, children were less likely to need mental health therapy or psychotropic medication. The
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trial proved that a good skills training curriculum with evidenced based practice was effective at
reducing risk and promoting health (Taussig & Culhane, 2010).
Discussion
It was unanimously concluded across all the articles that were reviewed that psychotropic
medications are prescribed at higher rates for foster children than the general population. This
poses several safety concerns, especially with medications that are considered high risk
medications, such as antipsychotics, and when polypharmacy is involved, as each comes with
serious adverse effects. It is also unsettling that many of the medications prescribed are not
approved for children or for the indicated reason that they were being prescribed. Furthermore,
prescribing rates were found to be erratic and vary based on demographics. Prescribing rates
should not only be lower but should also be consistent and based solely on symptomology and
diagnosis. A 2006 report from the Government Accountability Office (GAO) stated that 1 in 3
states recognized the use of psychotropic medication by the foster population to be among the
most pressing issues in the child welfare system (Rubin et al., 2012).
Another issue with the hasty prescribing of medications is that foster advocates do not
feel that they were able to participate in treatment planning and education, which is a protocol
outlined by the AACAP. A survey found that 48% of foster parents were not included in the
treatment planning for their kids, despite being responsible for ensuring the child follows the
treatment regimen and felt that physicians often prescribed medications in place of trying to get
to the root of mental health issues (Hayes, Geiger, & Lietz, 2015). Many parents consulted the
internet, friends, and social workers to gain information about treatment that should have been
explained by the provider. Foster parents have reported wanting more decision-making power in
their children’s care, being their advocate (Hayes, Geiger, & Lietz, 2015).
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Additionally, it seems that despite numerous organizations aside from the AACAP
attempting to create safety standards for psychotropic medication use among children in foster
care, such as the American Academy of Pediatrics and the Child Welfare League of America,
there is limited evidence that these guidelines are used in practice (Steele and Buchi, 2008;
Williams & Sherr, 2009). A study found that 47.9% of states endorsed that there should be a
state policy about foster children receiving a mental health evaluation (Mackie et al., 2011).
54.2% of states specified that they had policies about psychotropic medication, but 30.4% of
these policies were only regarding a subpopulation of children 6 years and younger (Mackie et
al, 2011). Only 2 states have specific policies against high risk medications like antipsychotics
(Mackie et al, 2011). 26.9% of states said that they had a policy regarding polypharmacy
(Mackie et al, 2011). Shockingly, only 29% of welfare agencies stated that they had policies
about psychotropic medication monitoring and oversight (Mackie et al, 2011). Perhaps it is not
that more policies are needed to regulate the use of psychotropic drugs, rather a more unified set
of guidelines with higher utilization and enforcement rates.
Moreover, regardless of the frequent attempts to create effective policy, one of the most
effective strategies for reducing the high prescribing rates may be through education. A blind
trial was done to determine if an educational session with current literature about psychotropic
medication would affect the habits and attitudes of prescribers and advocates regarding
psychoactive medication given to foster children. The results were that prescriptions for
psychoactive drugs from prescribers and advocates that attended the seminar immediately
decreased and continued to decrease for 7 months after the information session, dropping by
nearly 20% (Cohen, Lacasse, Duan & Sengelmann, 2013).
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One unexpected finding was that one of the ways that psychotropic medication was not
used according to protocol was that in some studies psychotropic medication was under
prescribed to foster children who were given a DSM diagnosis that qualified them for medical
treatment. Undertreatment was found to be an issue with 41% of people who met diagnostic
criteria for medical treatment of ADHD and 19% who met criteria for depression, yet they were
not prescribed any medication for it (Raghavan & McMillen, 2008).
The safer treatments such as psychosocial and behavioral therapy, should be used as first
line treatment for foster children and should continue as adjunct therapy even if it is determined
that medical treatment is necessary. Using psychoactive drugs to treat children should be avoided
unless all evidenced based practices, such as psychosocial treatments, have been expended, a
benefit versus risk analysis for the psychotropic medication comes out in favor of the benefit, the
prescriber of the medication is aware of all the effects of the medications, and close observation
of the child taking the medication is verified.
Limitations
There were several limitations to this review paper. Many of the papers reviewed for this
article obtained research based on Medicaid reports which were lacking in certain data points
leaving important variables unknown, like the accuracy of DSM diagnoses used to prescribe
psychotropic medication and what medications the children were on before entering foster care.
Also, the Medicaid reports were not verified by the foster children or parents who were included
in the report, so adherence and understanding of the medication regimen were often unknown.
Additionally, finding and relevant studies proved difficult because of the sensitive nature of the
subjects and because of a lack of available research on the topic. Furthermore, it was difficult to
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comprehensively conclude long term effects because of a lack of long term studies among the
foster population.
Suggestions for future research
Due to the overwhelming results that prove that there is an issue with prescribing
psychotropic medication to children in foster care that is not complicit with AACAP guidelines,
it is imperative that future research is determine ways to minimize the improper prescribing of
psychotropic medications. Ideas for future research would be to continue to follow prescribing
trends of psychotropic medications, to assess long term functional outcomes of psychotropic
treatment with and without adjunct psychosocial therapy, to do a longitudinal study to determine
if psychotropic medication is effective long term or if it is ineffective and discontinued, to
determine foster children with continuous care receive less medications then those with
fragmented care, to assess polypharmacy trends with psychotropic medication, to asses
prescribing habits among different providers to determine the factors that lead to demographic
based medication trends, and to determine the efficacy of psychotropic medications that are
currently being used without FDA approval. Additionally, it is important to determine which
medications and doses can safely be given to children, and to research how much foster children
and foster parents understand about their medication regimens and if they accurately follow
them.
Implications for nursing
As nurses, we are bound by the principles of beneficence and non-maleficence. It is our
duty to ensure that the patients that we treat are benefiting from our treatment and that the value
of the treatment outweighs the risks associated with it. We must ensure that protocol is being
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followed and that foster children receive timely mental health evaluations. Furthermore, any
opportunity to educate families about psychotropic medications, their adverse effects, and proper
administration should be done. Primary prevention of stressors should be utilized whenever
possible, and when medication is utilized, nurses should help ensure that there is proper
medication oversight. Additionally, as first line advocates, it is our duty to represent vulnerable
populations, like foster children, and advocate on their behalf to prescribing physicians, policy
makers, and legislators, to enlighten them about the needs of the population. Nurses in contact
with foster children should advocate for psychosocial and behavioral treatment, as well as
reducing the amount of psychotropic medication prescribed and the duration of time that children
remain on those medications. Lastly, it is important to aid foster parents in understanding the
Medicaid system to ensure that effective continuous care is obtained for their children.
Conclusion
This review was done because the trend of inappropriately prescribing psychotropic medications
to foster children poses a serious threat to a vulnerable population. This review helps determine
factors related to high prescribing rates of psychotropic medications, expose the risks related to
improper prescribing of psychotropic medication, and outline alternative treatment methods for
nurses and healthcare workers to consider in the future. Potential implications of this review are
that standardized medication safety procedures may be updated and alternative treatments to
medication may be utilized as fist line treatment for mental disorders in foster children.
Additionally, this review may highlight the need for more oversight and guardian education
about psychotropic medication.
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Appendices
Preliminary Data Search
Table 1: Table of study selection and review process.
Number of
studies found
using
keywords
Number of
Studies
meeting
inclusive
criteria
Number of
studies after
using
exclusion
criteria
Number of
studies after
excluding
duplicates

CINAHL
N= 118

Psychinfo
N=249

PubMed
N=481

ProQuest
Nursing
N= 4286

ProQuest
Sociology
N=1268

20

11

11

37

36

10

4

6

6

27

9

1

3

2

3

Total Selected articles: 18
Data Matrix
Table 2: Data summary of included articles.
Source

Sample

Method

Brenner,
Southerland
, Burns,
Wagner, &
Farmer,
2014

247
Randomi
foster
zed trial
children
(14
Treatm
ent
Foster
Homes)

Concepts Measured
•
•
•
•

Treatment
foster care
Psychotropic
medication
Polypharmac
y
Psychosocial
therapy

Alternative
Interventions
Randomized
test trial of
Treatment
Foster Care
Agencies

Results
A high
correlation
between
mental health
symptoms and
psychotropic
treatment and a
high rate of
polypharmacy
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Warner,
Song, &
Pottick,
2014

1,722
Survey
foster
children

•
•
•
•
•

Rubin,
Matone,
Huang,
dosReis,
Feudtner, &
Localio,
2012

686,080
foster
children
(based
on
Medicai
d files)

Data
analysis
with
logistical
regressio
n

Mackie et
al., 2011

58
(inform
ants)

Cross
sectional
national
study

•
•
•
•
•
•
•
•
•
•
•

Scozzaro &
Janikowski,
2015

200
(case
files) in
Northea
st
county

Case file
analysis

•
•
•
•
•

Mental
health
services
Psychotropic
medication
Primary
intervention
Adjunct
therapy
Continuity of
care
Polypharmac
y
Antipsychoti
cs
Psychotropic
treatment
Medicaid
Evidence
based
practice
Psychotropic
medication
policy
Medication
oversight
Mental
health
evaluation
Medication
consent
Polypharmac
y
antipsychotic
s
Demographic
s
Mental
health
Behavioral
therapy
Psychotropic
therapy
Mental
health

29

Outpatient
Among foster
mental health children
survey
presenting
problems
predicted
psychotropic
treatment

Prescriptions
filled

Use of
antipsychotics
and
polypharmacy
have increased

Interviews,
document
review, and
census
review

Psychotropic
medication
policy varies
by state if it
exists at all.
Most are rarely
followed

Case file
review

Foster children
have higher
rate of mental
health
diagnosis as
well as
psychotropic
medication and
behavioral
therapy
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•
•
Fontanella, 952
Gupta,
foster
Hianceyouth
Steelesmith,
&
Valentine,
2015

Longitudi
nal
cohort
study

•
•
•
•

Zito et al.,
2008

472
foster
youth in
southw
est
states

Random
sample
Medicaid
data
analysis

•
•
•
•
•
•
•
•

Cohen,
Lacasse,
Duan, &
Sengelman
n, 2013

4,000
prescrib
ers and
advocat
es

Blind
trial

•
•
•
•
•

Raghavan,
Lama, Kohl

5,501
foster

Cross
sectional

•

screening
and diagnosis
Evidence
based
practice
Adjunct
therapy
continuity of
care
serious
emotional
disturbance
bipolar and
schizophreni
a patients
lack of
screening
Medicaid
Psychotropic
monotherapy
Adjunct
therapy
Mental
health
disorders
Polypharmac
y
Antipsychoti
cs
Drugs by
class
Demographic
s
prescribers
Child welfare
workers
Education
Alternative
treatments
Evidence
based
practice
Psychotropic
trends

30

Outpatient
psychosocial
and medical
treatment

Less than half
sample
received
regular
outpatient
servicesdiscontinuous
care

Assessment
of Medicaid
data

Foster children
receive
psychotropic
treatment and
polypharmacy
at much higher
rate than
general
population

Educational
information
on
psychotropic
s
(CriticalThin
kRX
seminar)
National
Survey of

Education
seminar
decreased
prescription of
psychotropics

Child
characteristics
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&
Hamilton,
2010

children analysis

•
•

Steele &
6177
Database
Buchi, 2008 foster
analysis
children
in Utah

•
•
•
•
•

Linares,
MartinezMartin, &
Castellanos,
2013

252
kids (95
sibling
groups)
in New
York

Cohort
study
with
interview
s and
surveys

•
•
•
•
•
•
•

Raghavan
&
McMillen,
2008

403
Interview
foster
s
children
in
Midwes
tern
states

•
•
•
•
•

Hayes,

442

Foster

•

31

Mental
health
Foster
placement
Mental
health
condition
Psychotropic
use
Psychologica
l referrals
Mental
health
screening
Fragmented
care
demographic
s
antipsychotic
s and
stimulants
maltreatment
history
psychiatric
diagnosis
metabolic
effects
mental health
services
Evidence
based
practice

Child and
Adolescent
Well Being

rather than
mental health
need determine
prescription
Medical and Prevalence of
mental health mental health
evaluation
issues and that
psychotropic
medication use
increasing with
age

Caregiver
and child
assessments

correlations
with
prescription of
psychotropics
and long term
effects of
antipsychotics

Aging out
Polypharmac
y
Psychotropic
medication
use
Antipsychoti
cs
Mental
health
diagnosis
psychotropic

Interviews
based on
DSM IV and
medication
audits

Polypharmacy
correlates to
abuse or
psychiatric
disorder

Open ended

Parents
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Geiger, &
Lietz, 2015

foster
parents

parent
interview

•
•
•
•
•

Robst,
Armstrong,
& Dollard,
2011

Williams &
Sherr, 2009

1567
Data
foster
analysis
children
in
Florida
218
Interview
foster
and
children survey
analysis

•
•
•
•
•
•
•
•
•

Griffin,
14,103 CANS
McClelland foster
survey
, Holzberg, children
Stolbach,
Maj, &
Kisiel, 2011
dosReis,
Yoon,
Rubin,
Riddle,
Noll, &
Rothbard,
2011
Taussig &
Culhane,
2010

16,969
in MidAtlantic
region

Bivariate
statistical
analysis
based on
surveys

156
Randomi
foster
zed
children control
trial

•
•
•
•
•
•
•
•
•

treatment
behavioral
treatment
mental health
diagnosis
Medicaid
Continuity of
care
Adjunct
therapy
Treatment
foster care
Treatment
group care
Medicaid
Felonies
Medicaid
Emotional
disorders
DSM
diagnosis
Foster vs.
non- foster
youth
Screening
policy
CANS
decision
support tool
Mental
health
symptoms
policy
antipsychotic
s
psychiatric
diagnosis
lack of
screening

interview
with foster
parents

maltreated
children
mental health
functioning
psychiatric

Mental
health
therapy and
medical
treatment
Treatment
foster care
Psychosocial
and medical
treatment
Psychosocial
rehabilitation

32
satisfied with
case worker
intake but
dissatisfied and
confuse with
behavioral
therapy and
psychotropic
therapy
treatments
After TFC
children
committed less
feloniestreatment
successful
Evidence
based practice
and
psychosocial
treatment are
just as
effective in
foster youth

Mental
health
screenings
and medical
treatment

High incidence
of mental
health needs

Medication
treatment

High rate of
prolonged
concomitant
use and need
for monitoring

Mentoring
and skills
group“Fostering
Health

Skills training
and mentoring
effective at
treating mental
health
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•
•

symptoms
alternative
treatment
adjunct
therapy

Futures”
program
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